A global team of scientists has made a groundbreaking discovery of a new skeletal tissue known as “lipocartilage,” offering immense potential for regenerative medicine and tissue engineering.
FDA Expands Approval of Esketamine for Depression
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants,
January 22, 2025